EQS-News: Andera Partners Participates in the €45 Mil

EQS-News: Andera Partners / Key word(s): Financing Andera Partners Participates in the €45 Million Series B Financing of Grey Wolf Therapeutics, led by Pfizer Ventures, to Advance First-of-its-Kind Neoantigen Creation Approaches 26.01.2023 / 13:10 CET/CEST The issuer is solely responsible for th...

Related Keywords

Australia , Paris , France General , France , United Kingdom , Munich , Bayern , Germany , British , Andera Croissance , Sally Dewhurst , Rabab Nasrallah , Emma Johnson , Peter Joyce , Marie Claire Peakman , Bandera Co , Andera Life Sciences , Mc Services , Syndicate Of Life Science Industry Investors , Oxford Science Enterprises , Distribution Services , Andera Partners , Partners Participates , Seriesb Financing , Grey Wolf Therapeutics , Pfizer Ventures , Advance First Of Its Kind Neoantigen Creation , Life Science Industry Investors , Earlybird Venture Capital , British Patient , Support Advancement , Lead Candidate , British Patient Capital , Wolf Therapeutic , Grey Wolf , Oxford Science , Earlybird Venture , Claire Peakman , Wolf Therapeutics , Andera Midcap , Andera Expansion , Andera Co Invest , Andera Acto , Andera Infra , Bien Commun Advisory , Corporate News , Regulatory Announcements , Series , , Financing , Prey , Golf , Herapeutics , Pfizer , Dentures , Advance , First Of Its Kind , Eoantigen , Creation , Approaches , Et Cest , The ,